Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Chain Bridge I SPAC A | CBRG | Nov 15, 2024 | 11.49 | +0.17 |
Chain Bridge I Units | CBRGU | Nov 15, 2024 | 11.26 | 0.00 |
Champion Homes | SKY | Nov 15, 2024 | 97.08 | 0.00 |
Champions Oncology | CSBR | Nov 15, 2024 | 4.50 | +0.90 |
ChampionX | CHX | Nov 15, 2024 | 30.64 | -0.78 |
Chanson International | CHSN | Nov 15, 2024 | 5.85 | -3.78 |
ChargePoint | CHPT | Nov 15, 2024 | 1.12 | 0.00 |
Charles & Colvard | CTHR | Nov 15, 2024 | 1.30 | -2.92 |
Charles River Laboratories International | CRL | Nov 15, 2024 | 187.74 | -4.65 |
Charles Schwab | SCHW | Nov 15, 2024 | 80.64 | +0.56 |
Charlton Aria Acquisition Unit | CHARU | Nov 15, 2024 | 10.00 | 0.00 |
Chart Industries | GTLS-B | Nov 15, 2024 | 63.49 | -1.72 |
Chart Industries | GTLS | Nov 15, 2024 | 165.62 | -2.22 |
Charter Communications A | CHTR | Nov 15, 2024 | 389.57 | -1.19 |
Chatham Lodging Trust (REIT) A Pref | CLDT-A | Nov 15, 2024 | 23.60 | +0.30 |
Chatham Lodging Trust REIT | CLDT | Nov 15, 2024 | 8.86 | -1.56 |
Cheche Group | CCG | Nov 15, 2024 | 0.89 | -3.10 |
Check Point Software Technolgies | CHKP | Nov 15, 2024 | 174.25 | -1.86 |
Check-Cap | CHEK | Nov 15, 2024 | 0.77 | -3.32 |
Checkpoint Therapeutics | CKPT | Nov 15, 2024 | 3.43 | -9.26 |
Cheer Holding | CHR | Nov 15, 2024 | 2.62 | -2.24 |
Cheetah Mobile ADR | CMCM | Nov 15, 2024 | 4.17 | -1.18 |
Cheetah Net Supply Chain Service | CTNT | Nov 15, 2024 | 2.04 | -0.73 |
Chegg | CHGG | Nov 15, 2024 | 1.72 | +0.58 |
Chemed | CHE | Nov 15, 2024 | 557.95 | -0.77 |
Chemomab Therapeutics ADR | CMMB | Nov 15, 2024 | 1.68 | -3.74 |
Chemours | CC | Nov 15, 2024 | 18.89 | -2.23 |
Chemung Financial | CHMG | Nov 15, 2024 | 51.55 | +0.19 |
Chenghe Acquisition I Co A | LATG | Nov 15, 2024 | 11.67 | 0.00 |
Chenghe Acquisition I Units | LATGU | Nov 15, 2024 | 11.63 | +0.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.